Sharmila Makhija named chair of the Department of Obstetrics & Gynecology and Women’s Health at Albert Einstein College of Medicine

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

SHARMILA MAKHIJA was named professor and chair of the Department of Obstetrics & Gynecology and Women’s Health at Albert Einstein College of Medicine and Montefiore Health System, effective April 1.

Previously, Makhija served as chair and professor of obstetrics and gynecology at University of Louisville School Of Medicine.

Makhija has also held faculty positions at the University of Pittsburgh School of Medicine/Magee-Women’s Hospital, the University of Alabama at Birmingham School of Medicine, and Emory University School of Medicine.

She is a fellow of the American College of Obstetrics and Gynecology and a member of the American Medical Association, American Association of Cancer Research, and the American Society of Gynecologic Cancer. She is on the editorial board of the Journal of Oncology Practice and has served on the editorial boards of Women’s Oncology Review Journal and the International Journal of Gynecological Cancer.

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login